Latest News about Biotech
Recent news which mentions Biotech
Golden Cross Alert: Johnson & Johnson Shines With Ambrx Deal, Bullish Technical Signal
March 12, 2024
Tickers
JNJ
From Benzinga
Skin Disease-Focused AnaptysBio Earns Analyst Upgrade On Positive Outlook For Clinical Triggers
March 12, 2024
From Benzinga
From Benzinga
Podcast: Clearmind's Non-Hallucinogenic Psychoactive Molecule Could Become A Solution For Addictive Behaviors
March 12, 2024
From Benzinga
From Benzinga
Pfizer-Acquired Seagen's Adcetris Combo Therapy Extends Overall Survival Versus Placebo In Patients With Most Common Type Of Lymphoma
March 12, 2024
From Benzinga
From Benzinga
From Benzinga
Psyence Biomedical Will Undertake Psilocybin Clinical Trials For Palliative Care In Australia
March 11, 2024
Tickers
PBM
From Benzinga
Pfizer Shifts Strategic Focus, Pivoting From COVID To Cancer Drugs To Recover Market Value
March 11, 2024
From Benzinga
What's Going On With Moderna Stock On Monday?
March 11, 2024
From Benzinga
Anti-Counterfeiting Group Identifies Fake Diabetes Drug Ozempic in 16 Countries: Sparks Patient Harm Concerns
March 11, 2024
From Benzinga
What's Going On With Autoimmune/Inflammatory Disorder-Focused Ventyx Biosciences On Monday?
March 11, 2024
From Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.